Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LEVOSIMENDAN for Haemodynamic instability: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 5 adverse event reports in the FDA FAERS database where LEVOSIMENDAN was used for Haemodynamic instability.

Most Reported Side Effects for LEVOSIMENDAN

Side Effect Reports % Deaths Hosp.
Drug ineffective 64 35.0% 10 41
Cardiac failure 37 20.2% 10 30
Hypotension 37 20.2% 6 28
Off label use 28 15.3% 0 19
Respiratory failure 27 14.8% 4 16
Constipation 16 8.7% 0 16
Hypothyroidism 16 8.7% 0 16
Ejection fraction decreased 15 8.2% 4 14
Jugular vein distension 14 7.7% 0 14
Pulmonary hypertension 13 7.1% 0 11
Condition aggravated 12 6.6% 8 11
Cardiogenic shock 11 6.0% 1 10
Therapy non-responder 11 6.0% 4 6
Acidosis 10 5.5% 0 0
Pallor 10 5.5% 0 1

Other Indications for LEVOSIMENDAN

Product used for unknown indication (47) Cardiac failure (29) Cardiac failure congestive (18) Cardiogenic shock (15) Pulmonary hypertension (10) Cardiac failure acute (9) Hypotension (5)

Other Drugs Used for Haemodynamic instability

NOREPINEPHRINE (180) EPINEPHRINE (105) VASOPRESSIN (66) NOREPINEPHRINE\NOREPINEPHRINE (52) DOBUTAMINE (34) PHENYLEPHRINE (29) DOPAMINE (24) ALTEPLASE (16) AMIODARONE (12) HYDROCORTISONE (11)

Related Pages

LEVOSIMENDAN Full Profile All Haemodynamic instability Drugs LEVOSIMENDAN Demographics LEVOSIMENDAN Timeline